Predicting miRNA-disease association from heterogeneous information network with GraRep embedding model

In recent years, accumulating evidences have shown that microRNA (miRNA) plays an important role in the exploration and treatment of diseases, so detection of the associations between miRNA and disease has been drawn more and more attentions. However, traditional experimental methods have the limitations of high cost and time- consuming, a computational method can help us more systematically and effectively predict the potential miRNA-disease associations. In this work, we proposed a novel network embedding-based heterogeneous information integration method to predict miRNA-disease associations. More specifically, a heterogeneous information network is constructed by combining the known associations among lncRNA, drug, protein, disease, and miRNA. After that, the network embedding method Learning Graph Representations with Global Structural Information (GraRep) is employed to learn embeddings of nodes in heterogeneous information network. In this way, the embedding representations of miRNA and disease are integrated with the attribute information of miRNA and disease (e.g. miRNA sequence information and disease semantic similarity) to represent miRNA-disease association pairs. Finally, the Random Forest (RF) classifier is used for predicting potential miRNA-disease associations. Under the 5-fold cross validation, our method obtained 85.11% prediction accuracy with 80.41% sensitivity at the AUC of 91.25%. In addition, in case studies of three major Human diseases, 45 (Colon Neoplasms), 42 (Breast Neoplasms) and 44 (Esophageal Neoplasms) of top-50 predicted miRNAs are respectively verified by other miRNA-disease association databases. In conclusion, the experimental results suggest that our method can be a powerful and useful tool for predicting potential miRNA-disease associations.

[1]  Li-Ping Li,et al.  MLMDA: a machine learning approach to predict and validate MicroRNA–disease associations by integrating of heterogenous information sources , 2019, Journal of Translational Medicine.

[2]  Dong Wang,et al.  Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases , 2010, Bioinform..

[3]  J. Keller,et al.  RNA in Brain Disease: No Longer Just "The Messenger in the Middle" , 2007, Journal of neuropathology and experimental neurology.

[4]  C. Croce,et al.  MicroRNA-133 controls cardiac hypertrophy , 2007, Nature Medicine.

[5]  J. Teng,et al.  MicroRNA-195 downregulates Alzheimer's disease amyloid-β production by targeting BACE1 , 2012, Brain Research Bulletin.

[6]  Q. Cui,et al.  An Analysis of Human MicroRNA and Disease Associations , 2008, PloS one.

[7]  Thomas C. Wiegers,et al.  The Comparative Toxicogenomics Database: update 2019 , 2018, Nucleic Acids Res..

[8]  H. Nava,et al.  Palliation of malignant dysphagia in esophageal cancer: a literature-based review. , 2006, The journal of supportive oncology.

[9]  Jing Li,et al.  dbDEPC 2.0: updated database of differentially expressed proteins in human cancers , 2011, Nucleic Acids Res..

[10]  Xing Chen,et al.  PBMDA: A novel and effective path-based computational model for miRNA-disease association prediction , 2017, PLoS Comput. Biol..

[11]  Tyler E. Miller,et al.  MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1*♦ , 2008, Journal of Biological Chemistry.

[12]  Alejandro Pazos-Sierra,et al.  Diagnostic and treatment delay, quality of life and satisfaction with care in colorectal cancer patients: a study protocol , 2013, Health and Quality of Life Outcomes.

[13]  Brian J. Smith,et al.  Extracellular Matrix 1 (ECM1) Expression Is a Novel Prognostic Marker for Poor Long-Term Survival in Breast Cancer: A Hospital-Based Cohort Study in Iowa , 2009, Annals of Surgical Oncology.

[14]  M. Byrom,et al.  Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis , 2005, Nucleic acids research.

[15]  M. Latronico,et al.  Emerging role of microRNAs in cardiovascular biology. , 2007, Circulation research.

[16]  Hsien-Da Huang,et al.  miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions , 2017, Nucleic Acids Res..

[17]  V. Ambros microRNAs Tiny Regulators with Great Potential , 2001, Cell.

[18]  Qionghai Dai,et al.  WBSMDA: Within and Between Score for MiRNA-Disease Association prediction , 2016, Scientific Reports.

[19]  T. Tuschl,et al.  Mechanisms of gene silencing by double-stranded RNA , 2004, Nature.

[20]  Wei Tang,et al.  dbDEMC 2.0: updated database of differentially expressed miRNAs in human cancers , 2016, Nucleic Acids Res..

[21]  Yadong Wang,et al.  miR2Disease: a manually curated database for microRNA deregulation in human disease , 2008, Nucleic Acids Res..

[22]  Damian Szklarczyk,et al.  The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible , 2016, Nucleic Acids Res..

[23]  William A Robinson,et al.  Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma. , 2008, Blood.

[24]  Leif E. Peterson K-nearest neighbor , 2009, Scholarpedia.

[25]  Xia Li,et al.  Walking the interactome to identify human miRNA-disease associations through the functional link between miRNA targets and disease genes , 2013, BMC Systems Biology.

[26]  Núria Queralt-Rosinach,et al.  DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants , 2016, Nucleic Acids Res..

[27]  Lixu Yan,et al.  [Serum miR-103 as a potential diagnostic biomarker for breast cancer]. , 2012, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[28]  D. Bartel MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[29]  C. Brodley,et al.  Decision tree classification of land cover from remotely sensed data , 1997 .

[30]  Yuan Zhou,et al.  HMDD v3.0: a database for experimentally supported human microRNA–disease associations , 2018, Nucleic Acids Res..

[31]  Qiong Zhang,et al.  lncRNASNP2: an updated database of functional SNPs and mutations in human and mouse lncRNAs , 2017, Nucleic Acids Res..

[32]  F. Slack,et al.  The let-7 microRNA reduces tumor growth in mouse models of lung cancer , 2008, Cell cycle.

[33]  Qinghua Guo,et al.  LncRNA2Target v2.0: a comprehensive database for target genes of lncRNAs in human and mouse , 2018, Nucleic Acids Res..

[34]  E. Miska,et al.  How microRNAs control cell division, differentiation and death. , 2005, Current opinion in genetics & development.

[35]  Ana Kozomara,et al.  miRBase: from microRNA sequences to function , 2018, Nucleic Acids Res..

[36]  Xiao-ling Xu,et al.  MicroRNA-17, microRNA-18a, and microRNA-19a are prognostic indicators in esophageal squamous cell carcinoma. , 2014, The Annals of thoracic surgery.

[37]  Nong Ye,et al.  Naïve Bayes Classifier , 2013 .

[38]  David S. Wishart,et al.  DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..

[39]  M. S. Abdullah,et al.  Colorectal cancer: incidence and trend in Brunei Darussalam. , 2009, Singapore medical journal.

[40]  Daniel Kopans,et al.  Clinical Breast Examination: Practical Recommendations for Optimizing Performance and Reporting , 2004, CA: a cancer journal for clinicians.

[41]  Zhu-Hong You,et al.  PRMDA: personalized recommendation-based MiRNA-disease association prediction , 2017, Oncotarget.

[42]  Andy Liaw,et al.  Classification and Regression by randomForest , 2007 .

[43]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[44]  V. Ambros The functions of animal microRNAs , 2004, Nature.

[45]  B. Ponder,et al.  A Systematic Review Of Genetic Polymorphisms and Breast Cancer Risk 1 , 2000 .

[46]  Donglin Wang,et al.  MicroRNA expression in esophageal squamous cell carcinoma: Novel diagnostic and prognostic biomarkers. , 2017, Molecular medicine reports.

[47]  Xing Chen,et al.  LncRNADisease: a database for long-non-coding RNA-associated diseases , 2012, Nucleic Acids Res..

[48]  D. Bartel MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[49]  Yadong Wang,et al.  Prioritization of disease microRNAs through a human phenome-microRNAome network , 2010, BMC Systems Biology.

[50]  Decheng Yang,et al.  MicroRNA: an Emerging Therapeutic Target and Intervention Tool , 2008, International journal of molecular sciences.

[51]  Lei Wang,et al.  BNPMDA: Bipartite Network Projection for MiRNA–Disease Association prediction , 2018, Bioinform..

[52]  M. He,et al.  Integrated analysis of gene expression signatures associated with colon cancer from three datasets. , 2018, Gene.

[53]  E. Wiemer The role of microRNAs in cancer: no small matter. , 2007, European journal of cancer.

[54]  Xantha Karp,et al.  Encountering MicroRNAs in Cell Fate Signaling , 2005, Science.

[55]  S. Franceschi,et al.  EPIDEMIOLOGY OF ESOPHAGEAL CANCER , 2013 .

[56]  Mohammed Al-Shalalfa,et al.  Using context-specific effect of miRNAs to identify functional associations between miRNAs and gene signatures , 2013, BMC Bioinformatics.

[57]  Raquel Díaz,et al.  Deregulated expression of miR‐106a predicts survival in human colon cancer patients , 2008, Genes, chromosomes & cancer.

[58]  Yang Li,et al.  HMDD v2.0: a database for experimentally supported human microRNA and disease associations , 2013, Nucleic Acids Res..

[59]  Qiongkai Xu,et al.  GraRep: Learning Graph Representations with Global Structural Information , 2015, CIKM.